This article summarizes a conversation with Trish Nettleship, Director, Social Media & Influence, UCB, Inc., about her company's approach to social media listening.
This article is a summary of a study that evaluated claims in consumer-targeted television drug advertising against pharmacological evidence in order to determine the frequency of false or misleading claims made in these ads.
Measuring Physician Interaction with Pharma Brands: Medikly’s Physician Value Index is a New Tool...
Venkat Gullapalli, MD and Mark Goldstone, Co-CEOs of Medikly, spoke on the Pharma marketing Talk show about PV Index™. This article summarizes that discussion.
Welcome to Volume 12, Issue #9 (December 2013) of Pharma Marketing News.
Pharmaguy’s Social Media Compendium: A Comprehensive History & Guide to the Pharmaceutical Industry’s Social...
Welcome to Pharmaguy's Social Media Compendium, which is a catalog of articles, blog posts, podcasts, and surveys, all documenting the use of social media by the pharmaceutical industry from 2005 through today. Through this compendium you are able to relive the fascinating history of the pharmaceutical industry's social media trials & tribulations and ultimate triumphs.
Pharma Marketing Ethics & Corporate Reputation Compendium: Bad, Devalued, Distrusted & Defensive Pharma
Welcome to The Pharma Marketing Ethics & Corporate Reputation Compendium, which is a catalog of articles, blog posts, podcasts, and surveys about the pharmaceutical industry's marketing practices viz-a-viz ethics and its corporate reputation.
Welcome to Volume 12, Issue #8 (October 2013) of Pharma Marketing News.
This article reviews social media breakthroughs by Boehringer, AstraZeneca, & Janssen.
Ethicists identify six 'principles of influence' that are key to the drug industry’s routine marketing strategies, which rely on the illusion that the industry is a generous avuncular partner to physicians.
This article is a review of CMS's OpenPayments App for Physicians and Industry.